Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017 Continue Reading »
Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017 Continue Reading »
New ADA guidelines encourage interrupting long periods of sitting: improved blood glucose management and insulin sensitivity Continue Reading »
Public workshop scheduled at FDA for August 29, 2016. Get involved! Continue Reading »
Why the FDA may change its definition of healthy, and how it could impact people with diabetes. Plus, what's coming to nutrition labels? Continue Reading »
Launch before the second half of 2016. What savings program will be offered? Continue Reading »
Comment by March 26 to ensure that diabetes devices easily communicate with one another, other devices, and software. Continue Reading »
Increased focus on sleep, mental health, and behavior – what other changes were made? Continue Reading »